anaphylaxis_ a guide to management _ page 13

Upload: anonymous-8kn8ir1gtw

Post on 02-Jun-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Anaphylaxis_ a Guide to Management_Page13

    1/2

    9/14/2014 Anaphylaxis: a guide to management : Page 13

    http://learning.bmj.com/learning/modules/flow/ICH.html?execution=e3s15&moduleId=5001088&status=LIVE&action=start&_flowId=ICH&sessionTimeo

    My AccountUpdate my detailsUpdate my emails

    SubscribeUse access codeAthens users sign in hereShibboleth access

    Site settings

    Go to BMJ Portfolio to change your accreditation settings

    EnglishSign out

    Search BMJ Learning Search

    Browse by specialty

    Anaphylaxis: a guide to management

    5. Why should you refer this patient to an allergy clinic?

    Your answerCorrect

    answer

    a.The cause of the reaction was unclear

    b.Refer all patients presenting with anaphylaxis to an allergy clinic

    c.His reaction was severe with tongue swelling and breathlessness

    d.Latex allergy is suspected

    a : The cause of the reaction was unclear

    Refer all patients presenting with anaphylaxis to an allergy clinic.

    b : Refer all patients presenting with anaphylaxis to an allergy clinic

    Refer all patients presenting with anaphylaxis to an allergy clinic to identify the cause, thereby reducing the risk of future reactions and preparing the patient tomanage future episodes themselves. There is a list of specialist clinics on the British Society for Allergy and Clinical Immunology (BSACI) website.

    c : His reaction was severe with tongue swelling and breathlessness

    Refer all patients presenting with anaphylaxis to an allergy clinic.

    d : Latex allergy is suspected

    Refer all patients presenting with anaphylaxis to an allergy clinic.

    Learning bite: adrenaline autoinjectors

    Information on adrenaline autoinjectors is available at: http://www.anaphylaxis.org.uk. Adrenaline autoinjectors are all single-use devices and should be disposed

    http://learning.bmj.com/learning/home.html?locale=en_GBhttp://learning.bmj.com/learning/home.html?locale=en_GBhttp://learning.bmj.com/learning/home.html?locale=en_GBhttp://learning.bmj.com/learning/home.html?locale=en_GBhttp://www.anaphylaxis.org.uk/http://www.bsaci.org/http://learning.bmj.com/learning/modules/atoz/.html?locale=en_GBhttp://learning.bmj.com/learning/logout.htmlhttp://portfolio.bmj.com/portfolio/prefs/user-prefs-popup.html?userPrefOpt=settingshttp://learning.bmj.com/learning/shibboleth.html?action=preAuthentication&encodedPath=http://learning.bmj.com/learning/Athens.htmlhttp://learning.bmj.com/learning/user/voucher.htmlhttp://learning.bmj.com/learning/info/subscribe.html?locale=en_GBhttp://learning.bmj.com/learning/update-profile.html?action=preUpdate&anchor=1http://learning.bmj.com/learning/update-profile.html?action=preUpdate&anchor=0&editDetails=truehttp://learning.bmj.com/learning/home.html?locale=en_GB
  • 8/10/2019 Anaphylaxis_ a Guide to Management_Page13

    2/2

    9/14/2014 Anaphylaxis: a guide to management : Page 13

    http://learning.bmj.com/learning/modules/flow/ICH.html?execution=e3s15&moduleId=5001088&status=LIVE&action=start&_flowId=ICH&sessionTimeo

    of safely after use.

    Advise patients prescribed adrenaline autoinjectors to carry them at all times, along with anti-histamines, in an emergency treatment pack. Offer patients ademonstration of correct use of the adrenaline injector prior to discharge. Explain that it is recommended that the currently available autoinjectors are graspedcentrally to minimise the chances of accidental injection of adrenaline into a thumb or fingerTrainer devices to practice with (without a needle) are available via the manufacturers websites. These websites also show step by step instructions on howto use the devices. The ones currently listed in the British National Formulary are: Epipen, Jext, and Emerade. Emerade is the most recent single-useadrenaline auto-injector to become available. It is available in a 500 g dose in addition to the 300 g dose and 150 g dose for children weighing 15-30 kg.The new Epipen has a blue safety cap and an orange needle cover: blue to sky, orange to thigh

    Previous

    Print

    Save and continue

    Contact us

    Terms & conditions

    Privacy and cookie policy

    Revenue sources

    2014 BMJ Publishing Group Ltd

    http://group.bmj.com/group/arefbout/revenue-sourceshttp://group.bmj.com/group/about/legal/privacyhttp://group.bmj.com/group/about/legal/termshttp://learning.bmj.com/learning/contact.html?locale=en_GBhttp://www.emerade.com/http://www.jext.co.uk/https://www.epipen.com/http://www.anaphylaxis.org.uk/